Cross-neutralization of cutaneous and mucosal Papillomavirus types with anti-sera to the amino terminus of L2. (Q34417608)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15885736%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

title

Cross-neutralization of cutaneous and mucosal Papillomavirus types with anti-sera to the amino terminus of L2 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15885736%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15885736%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Diana V. Pastrana

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15885736%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

10

Richard B S Roden

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15885736%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

4

Yuk-Ying S Pang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15885736%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

8

Douglas R Lowy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15885736%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

Ratish Gambhira

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15885736%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Cynthia D Thompson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15885736%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Timothy D Culp

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15885736%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Neil D Christensen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15885736%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

John T Schiller

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15885736%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

language of work or name

English

0 references

publication date

1 July 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15885736%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

number of pages

8

1 reference

inferred from page(s)

published in

Virology

1 reference

2 August 2017

337

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15885736%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

365-372

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15885736%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15885736%20AND%20SRC:MED&resulttype=core&format=json

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

11 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.011

Efficient intracellular assembly of papillomaviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.011

Maturation of papillomavirus capsids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.011

A peptide encoding a B-cell epitope from the N-terminus of the capsid protein L2 of bovine papillomavirus-4 prevents disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.011

Vaccination of cattle with the N-terminus of L2 is necessary and sufficient for preventing infection by bovine papillomavirus-4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.011

Neutralization of CRPV infectivity by monoclonal antibodies that identify conformational epitopes on intact virions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.011

The open reading frame L2 of cottontail rabbit papillomavirus contains antibody-inducing neutralizing epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.011

Human papillomavirus types 6 and 11 have antigenically distinct strongly immunogenic conformationally dependent neutralizing epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.011

Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.011

Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.011

Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.011

Quantitative RT-PCR assay for HPV infection in cultured cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.011

Kinetics of in vitro adsorption and entry of papillomavirus virions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.011

Protective immunity to rabbit oral and cutaneous papillomaviruses by immunization with short peptides of L2, the minor capsid protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.011

Comparison of neutralization of BPV-1 infection of C127 cells and bovine fetal skin xenografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.011

Immunological analyses of human papillomavirus capsids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.011

Nasal immunization of mice with peptide having a cross-neutralization epitope on minor capsid protein L2 of human papillomavirus type 16 elicit systemic and mucosal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.011

Safety and immunogenicity of a peptide containing the cross-neutralization epitope of HPV16 L2 administered nasally in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.011

A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.011

Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.011

A controlled trial of a human papillomavirus type 16 vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.011

Enhancement of capsid gene expression: preparing the human papillomavirus type 16 major structural gene L1 for DNA vaccination purposes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.011

Sequence close to the N-terminus of L2 protein is displayed on the surface of bovine papillomavirus type 1 virions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.011

Against which human papillomavirus types shall we vaccinate and screen? The international perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.011

T-Coffee: A novel method for fast and accurate multiple sequence alignment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.011

Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.011

Minor capsid protein of human genital papillomaviruses contains subdominant, cross-neutralizing epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.011

Positively charged termini of the L2 minor capsid protein are necessary for papillomavirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.011

Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.011

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.011

Cell surface-binding motifs of L2 that facilitate papillomavirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.011

Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.011

Common neutralization epitope in minor capsid protein L2 of human papillomavirus types 16 and 6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.011

Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.011

7 January 2021

inferred from DOI database lookup

Monoclonal antibody-mediated neutralization of infectious human papillomavirus type 11

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.011

7 January 2021

inferred from DOI database lookup

Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.011

7 January 2021